These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, Simon P. Lancet; 1997 Mar 08; 349(9053):667-74. PubMed ID: 9078197 [Abstract] [Full Text] [Related]
3. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Cairns JA, Connolly SJ, Roberts R, Gent M. Lancet; 1997 Mar 08; 349(9053):675-82. PubMed ID: 9078198 [Abstract] [Full Text] [Related]
9. Lessons from antiarrhythmic trials involving class III antiarrhythmic drugs. Yap YG, Camm AJ. Am J Cardiol; 1999 Nov 04; 84(9A):83R-89R. PubMed ID: 10568665 [Abstract] [Full Text] [Related]
16. Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists? Stevenson WG, Ridker PM. JAMA; 1996 Aug 14; 276(6):481-5. PubMed ID: 8691557 [Abstract] [Full Text] [Related]
17. Beneficial effect of amiodarone on cardiac mortality in patients with asymptomatic complex ventricular arrhythmias after acute myocardial infarction and preserved but not impaired left ventricular function. Pfisterer M, Kiowski W, Burckhardt D, Follath F, Burkart F. Am J Cardiol; 1992 Jun 01; 69(17):1399-402. PubMed ID: 1590226 [Abstract] [Full Text] [Related]